Annals of Emergency Medicine
Volume 54, Issue 2 , Pages 226-235.e2 , August 2009

Cost-Effectiveness of Lay Responder Defibrillation for Out-of-Hospital Cardiac Arrest

  • Graham Nichol, MD

      Affiliations

    • University of Washington, Seattle, WA
    • Corresponding Author InformationAddress for reprints: Graham Nichol, MD, University of Washington Harborview Center for Prehospital Emergency Care, Box 359727, 325 Ninth Avenue, Seattle, WA 98104; 206-521-1728, Fax 206-521-1784
    • ,
  • Ella Huszti, MSc

      Affiliations

    • McGill University, Montreal, Quebec, Canada
    • ,
  • Alice Birnbaum, MA

      Affiliations

    • Axio Research Inc., Seattle, WA
    • ,
  • Brian Mahoney, MD

      Affiliations

    • University of Minnesota, Minneapolis, MN
    • ,
  • Myron Weisfeldt, MD

      Affiliations

    • Johns Hopkins University, Baltimore, MD
    • ,
  • Andrew Travers, MD

      Affiliations

    • Dalhousie University, Halifax, Nova Scotia, Canada
    • ,
  • Jim Christenson, MD

      Affiliations

    • University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Karen Kuntz, ScD

      Affiliations

    • Harvard School of Public Health, Boston, MA
    • ,
  • PAD Investigators

Received 9 May 2007 ,Revised 5 December 2008 ,Accepted 21 January 2009.

References 

  1. National Center for Health Statistics. Detailed Diagnoses and Procedures, National Hospital Discharge Survey, 1990. Hyattsville, MD: National Center for Health Statistics; 1992;DHHS Publication No. 92-1774
  2. Nichol G, Stiell IG, Laupacis A, et al. A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med. 1999;34:517–525
  3. Hallstrom AP, Ornato JP, Weisfeldt M, et al. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med. 2004;351:637–646
  4. Nichol G, Wells GA, Kuntz K, et al. Methodological design for economic evaluation in Public Access Defibrillation (PAD) trial. Am Heart J. 2005;150:202–208
  5. Gold MR, Siegel JE, Russell LB, et al. Appendix A: summary recommendations. In:  Gold MR,  Siegel JE,  Russell LB, et al. editor. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996;p. 425
  6. Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40:113–128
  7. Drummond MF, O'Brien BJ, Stoddart GL, et al. Collection and Analysis of Data (Methods for the Economic Evaluation of Health Care Programs). 2d ed.. Oxford, England: Oxford University Press; 1997;232–264
  8. Stinnett AA, Paltiel AD. Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means. Med Decis Making. 1997;17:483–489
  9. Creasey MA. Limits for the ratio of means. J R Stat Soc B. 1954;16:186–194
  10. Naimark D, Krahn MD, Naglie G, et al. Primer on medical decision analysis: part 5—working with Markov processes. Med Decis Making. 1997;17:152–159
  11. TreeAge Software Inc. Decision Analysis by TreeAge (DATA for Windows. Version 4.0. User's Manual). Boston, MA: TreeAge Software Inc; 2001;
  12. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programs. 3rd ed.. Oxford, England: Oxford University Press; 2005;
  13. Russell LB, Siegel JE, Daniels N, et al. Cost-effectiveness analysis as a guide to resource allocation in health: roles and limitations. In:  Gold MR,  Siegel JE,  Russell LB, et al. editor. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996;p. 3–24
  14. Bardy GH, Lee KL, Mark DB, et al. Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med. 2008;358:1793–1804
  15. Fenwick E, Marshall DA, Levy AR, et al. Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res. 2006;6:52
  16. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ. 1994;3:95–104
  17. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman and Hall; 1993;
  18. de Wit GA, Ramsteijn PG, de Charro FT. Economic evaluation of end stage renal disease treatment. Health Policy. 1998;44:215–232
  19. CDC Diabetes Cost-Effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287:2542–2551
  20. Graham JD, Thompson KM, Goldie SJ, et al. The cost-effectiveness of air bags by seating position. JAMA. 1997;278:1418–1425
  21. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet. 2002;3:872–882
  22. Valenzuela TD, Roe DJ, Nichol G, et al. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med. 2000;343:1206–1209
  23. Katz KA, Bernstein KT, Klausner JD. Does ascertainment bias affect reports on the incidence of multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus infection?. Ann Intern Med. 2008;149:65;author reply 66
  24. Sayre MR, Travers AH, Daya M, et al. Measuring survival rates from sudden cardiac arrest: the elusive definition. Resuscitation. 2004;62:25–34
  25. Roine RO, Kajaste S, Kaste M. Neuropsychological sequelae of cardiac arrest. JAMA. 1993;269:237–242
  26. Becker L, Eisenberg M, Fahrenbruch C, et al. Public locations of cardiac arrest (Implications for public access defibrillation). Circulation. 1998;97:2106–2109
  27. Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychology. 1982;1:61–80
  28. Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ. 1992;146:473–481
  29. King JT, Tsevat J, Lave JR, et al. Willingness to pay for a quality-adjusted life-year: implications for societal health care resource allocation. Med Decis Making. 2005;25:667–677
  30. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med. 2005;352:222–224
  31. Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;16:1–31
  32. Nichol G, Powell J, van Ottingham L, et al. Consent in resuscitation trials: benefit or harm for patients and society?. Resuscitation. 2006;70:360–368
  33. Nichol G, Hallstrom A, Ornato JP, et al. Potential cost-effectiveness of public access defibrillation in the United States. Circulation. 1998;97:1315–1320
  34. Nichol G, Laupacis A, Stiell I, et al. A cost-effectiveness analysis of potential improvements to emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med. 1996;27:711–720
  35. Groeneveld PW, Kwong JL, Liu Y, et al. Cost-effectiveness of automated external defibrillators on airlines. JAMA. 2001;286:1482–1489
  36. Caffrey SL, Willoughby PJ, Pepe PE, et al. Public use of automated external defibrillators. N Engl J Med. 2002;347:1242–1247
  37. Nichol G, Valenzuela T, Roe D, et al. Cost-effectiveness of defibrillation by targeted responders in public settings. Circulation. 2003;108:697–703
  38. Walker A, Sirel JM, Marsden AK, et al. Cost-effectiveness and cost utility model of public place defibrillators in improving survival after prehospital cardiopulmonary arrest. BMJ. 2003;327:1316–1320
  39. Boyle M, Furlong W, Torrance G, et al. Reliability of the Health Utilities Index-Mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire. Qual Life Res. 1995;4:249–257
  40. Feeny D, Furlong W, Boyle W, et al. Multi-attribute health status classification systems: Health Utilities Index. PharmacoEconomics. 1995;7:490–502
  41. Nichol G, Stiell IG, Hebert P, et al. What is the quality of life of survivors of cardiac arrest? a prospective study. Acad Emerg Med. 1999;6:95–102
  42. Bergner L, Bergner M, Hallstrom AP, et al. Service factors and health status of survivors of out-of-hospital cardiac arrest. Am J Emerg Med. 1983;1:259–263
  43. Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA. 2008;300:1423–1431
  44. Lerner EB, Nichol G, Spaite DW, et al. A comprehensive framework for determining the cost of an emergency medical services system. Ann Emerg Med. 2007;49:304–313
  45. Mohr PE, Cheng CM, Mueller CD. Establishing a fair Medicare reimbursement for low-volume rural ambulance providers. Policy Anal Brief W Ser. 2001;4:1–4
  46. Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;33:1576–1583
  47. Larsen G, Hallstrom A, McAnulty J, et al. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy. Circulation. 2002;105:2049–2057
  48. Luce BR, Manning WG, Siegel JE, et al. Estimating costs in cost-effectiveness analysis. In:  Gold MR,  Siegel JE,  Russell LB, et al. editor. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996;p. 176–213
  49. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J. 2000;21:2071–2078

 Provide feedback on this article at the journal's Web site, www.annemergmed.com.

 Supervising editor: Theodore R. Delbridge, MD, MPH

 Author contributions: GN, EH, and KK conceived the study, designed the trial, and obtained research funding. GN, EH, and AB supervised the conduct of the trial and data collection. AB undertook recruitment of participating centers and patients and managed the data, including quality control. EH, AB, and KK provided statistical advice on study design and analyzed the data. GN drafted the article, and all authors contributed substantially to its revision. GN takes responsibility for the paper as a whole.

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. For full disclosures, see Appendix E2, available at http://www.annemergmed.com.

 Publication date: Available online March 25, 2009.

PII: S0196-0644(09)00101-2

doi: 10.1016/j.annemergmed.2009.01.021

Annals of Emergency Medicine
Volume 54, Issue 2 , Pages 226-235.e2 , August 2009

Article Tools

* Image Usage & Resolution